We are live on ! Find out more
TEE

Tibra Equities Europe Portfolio holdings

AUM $90.4M
1-Year Est. Return 37.81%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
10 Year Est. Return
AUM
$667M
AUM Growth
+$95.3M
Cap. Flow
+$46.5M
Cap. Flow %
6.98%
Top 10 Hldgs %
42.33%
Holding
285
New
96
Increased
7
Reduced
11
Closed
169

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$54.5M
2
ABBV icon
AbbVie
ABBV
+$18.1M
3
CSCO icon
Cisco
CSCO
+$16.8M
4
CHE icon
Chemed
CHE
+$15.5M
5
CELG
Celgene Corp
CELG
+$13.3M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$36M
2
BA icon
Boeing
BA
+$28.2M
3
KO icon
Coca-Cola
KO
+$21.8M
4
DD icon
DuPont de Nemours
DD
+$20.5M
5
JNJ icon
Johnson & Johnson
JNJ
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.94%
2 Healthcare 18.77%
3 Financials 7.8%
4 Consumer Discretionary 5.7%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
226
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-128
Closed -$317K
PACW
227
DELISTED
PacWest Bancorp
PACW
-11,169
Closed -$553K
AMRS
228
DELISTED
Amyris Inc.
AMRS
-44,157
Closed -$295K
RUTH
229
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-12,740
Closed -$311K
ALBO
230
DELISTED
Albireo Pharma Inc
ALBO
-18,101
Closed -$590K
UMPQ
231
DELISTED
Umpqua Holdings Corp
UMPQ
-32,285
Closed -$691K
SRNE
232
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-151,623
Closed -$781K
AVYA
233
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-245,895
Closed -$5.51M
RSX
234
DELISTED
VanEck Russia ETF
RSX
-46,723
Closed -$1.06M
AMPE
235
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-574
Closed -$585K
USAK
236
DELISTED
USA Truck Inc
USAK
-15,302
Closed -$390K
MANT
237
DELISTED
Mantech International Corp
MANT
-36,021
Closed -$2M
SFUN
238
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
-7,403
Closed -$1.9M
JOBS
239
DELISTED
51job Inc
JOBS
-38,688
Closed -$3.33M
DRNA
240
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-76,823
Closed -$734K
MDP
241
DELISTED
Meredith Corporation
MDP
-37,344
Closed -$2.01M
KDMN
242
DELISTED
Kadmon Holdings, Inc.
KDMN
-152,169
Closed -$647K
SLCT
243
DELISTED
Select Bancorp, Inc.
SLCT
-23,956
Closed -$320K
HPR
244
DELISTED
HighPoint Resources Corporation
HPR
-1,244
Closed -$316K
PRGX
245
DELISTED
PRGX Global, Inc.
PRGX
-41,175
Closed -$389K
CBMG
246
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
-27,777
Closed -$487K
HDS
247
DELISTED
HD Supply Holdings, Inc.
HDS
-27,260
Closed -$1.03M
GPOR
248
DELISTED
Gulfport Energy Corp.
GPOR
-25,230
Closed -$243K
BITA
249
DELISTED
Bitauto Holdings Limited
BITA
-19,494
Closed -$412K
ZN
250
DELISTED
Zion Oil & Gas, Inc.
ZN
-121,081
Closed -$576K

Similar funds

Tibra Equities Europe's Q2 2018 Portfolio in Review

As of Q2 2018, Tibra Equities Europe held 285 positions worth $667M, up 17% from $571M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Tibra Equities Europe deployed $46.5M of net new capital in Q2 2018, opening 96 new positions and adding to 7 existing holdings. Its largest new stake was Apple: 1,201,216 shares worth $55.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $20.5M trimmed.

  • Tibra Equities Europe's largest Q2 2018 buy was Apple: 1,201,216 shares worth $55.6M.
  • Tibra Equities Europe added most to Royal Dutch Shell PLC ADS Class A in Q2 2018, an estimated $9.7M increase.
  • Tibra Equities Europe's biggest Q2 2018 reduction was DuPont de Nemours, cutting an estimated $20.5M.
  • Tibra Equities Europe fully exited Microsoft in Q2 2018, selling an estimated $36M.
  • Tibra Equities Europe's ten largest holdings make up 42% of its $667M portfolio in Q2 2018.
  • Tibra Equities Europe opened 96 new positions and closed 169 in Q2 2018.
  • Tibra Equities Europe's portfolio value rose 17% quarter-over-quarter to $667M.

Based on Tibra Equities Europe's 13F filing for Q2 2018, filed 10 Aug 2018.